Therapeutic Sales Specialist - FOCUS ON THE PSYCHEDELIC SPACE - Building a world-class sales team - Providence, RI

About the Role

The Therapeutic Sales Specialist (TSS) is a field-based, individual contributor role responsible for driving adoption and appropriate use of an innovative mental health therapy at certified treatment centers within a defined territory covering Providence, New Bedford, Cape Cod, Norwich, CT, and the surrounding areas. This role executes the regional commercial strategy by developing strong partnerships with psychiatrists, healthcare providers, and integrated care systems while ensuring alignment with regulatory, safety, and patient access frameworks. The TSS will play a critical role in launching a novel therapeutic modality, engaging providers through a highly consultative, clinically driven approach. This position operates at the intersection of clinical education, account management, and patient access, helping to shape a new treatment ecosystem in mental health.

Location: Field-based with up to 70% travel, dependent upon geography.

Responsibilities

• Execute territory-level commercial strategy to support the successful launch and uptake of the company’s innovative mental health therapy.
• Develop and maintain strategic relationships with psychiatrists, treatment centers, behavioral health systems, and other key stakeholders.
• Deliver scientifically accurate, compliant, and compelling product and disease-state education to healthcare providers.
• Identify appropriate patients and support healthcare providers in understanding patient selection and referral pathways.
• Collaborate with certified treatment sites to support onboarding, readiness, and optimization of treatment delivery workflows.
• Navigate site-of-care dynamics, including scheduling, patient flow, and operational considerations unique to the treatment model.
• Partner cross-functionally with Medical Affairs, Market Access, Patient Support, and Commercial Operations to ensure coordinated execution.
• Support patient access by understanding reimbursement pathways, assisting providers with access-related challenges, and connecting to relevant resources.
• Gather and communicate actionable field insights to inform brand strategy, patient journey optimization, and launch execution.
• Manage territory business planning, including account prioritization, call planning, and performance tracking.
• Demonstrate highly ethical, compliant, and patient-centric behaviors in all engagements.
• Contribute to a culture of collaboration, accountability, and continuous learning within the broader sales organization.

Requirements

• Bachelor’s degree required; advanced degree preferred.
• 5–8+ years of pharmaceutical or biotech sales experience, preferably in specialty or complex therapeutic areas.
• Experience in psychiatry, CNS, or behavioral health markets is preferred.
• Familiarity with medical and pharmacy benefit reimbursement, buy-and-bill, and site-of-care dynamics.
• Understanding of prior authorization and payer processes.
• Demonstrated success in launching novel therapies or operating in pre-launch environments.
• Experience working with specialty treatment centers, IDNs, academic medical centers, or complex site-of-care models is preferred.
• Strong clinical acumen and ability to communicate complex scientific concepts clearly and compellingly.
• Proven track record of building trust-based relationships with healthcare providers.
• Experience supporting therapies requiring site certification, specialized administration, or coordinated care delivery models is highly desirable.
• Highly collaborative with the ability to work effectively across cross-functional teams.
• Strong business acumen, territory management, and organizational skills.

About the Company

Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Headquartered in London, UK, with offices in New York City, the company focuses on developing novel treatments to improve the lives of those suffering from mental health conditions who are not helped by current treatments. Compass is pioneering a new paradigm for mental health treatment through the development of its investigational COMP360 synthetic psilocybin treatment, a potential first-in-class therapy. COMP360 has received Breakthrough Therapy designation from the FDA and Innovative Licensing and Access Pathway (ILAP) designation in the UK for treatment-resistant depression (TRD). The company is currently in phase 3 trials for TRD, has completed phase 2 studies for PTSD and anorexia nervosa, and is planning further late-stage studies in PTSD.